Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • AstraZeneca vaccine elicits stronger T-cell response in elderly than Pfizer jab
    • EU bets big on BioNTech/Pfizer jab as Danes stop giving AstraZeneca
    • Europe’s low-tax nations braced for struggle over US corporate tax plan
    • Ponzi mastermind Bernard Madoff dies aged 82
    • Can mixing Covid vaccines work?
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Investors brace for ‘major shift’ as momentum and value collide
    • Coinbase valued at $76bn in coming-of-age moment for cryptocurrency
    • Coinbase listing set to capitalise on crypto bull run
    • US pushes Japan to back Taiwan at Biden-Suga summit
    • Former world leaders call on Biden to suspend Covid-19 vaccine patents
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • HSBC relocates top leadership from London to Hong Kong
    • JPMorgan earnings surge on strengthening US economy
    • Gupta carved up business empire in attempt to secure UK Covid loans
    • General Atlantic pays up to exit controversial €300m Greensill loan
    • Unilever’s ‘skin lightening’ cream tests its purpose
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Global stocks have a mixed day as US earnings season kicks off
    • O2-Virgin Media £31bn merger cleared by UK competition watchdog
    • Bonds of China’s largest bad debt investor plunge to record low
    • Tech stocks and Treasuries rise as investors look past inflation data
    • Private lenders to emerging markets face threat
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why we shouldn’t worry about Covid vaccine blood clots
    • China’s digital currency is a threat to dollar dominance
    • Unilever’s ‘skin lightening’ cream tests its purpose
    • Bounty of Serbian vaccine diplomacy shames the EU
    • Muddling through is Johnson’s only strategy to save the Union
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • The cross-border pitfalls of ‘working from anywhere’
    • I am 76 — should I reveal my age when applying for board positions?
    • A reading list to prepare for a post-pandemic age
    • What a bleak AI future tells us about how to work now
    • FT launches its annual business book prize
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Why we shouldn’t worry about Covid vaccine blood clots
    • The vanishing billionaire: how Jack Ma fell foul of Xi Jinping
    • How can I reduce the tax on my pension?
    • Amazon’s Leonardo: portrait of the genius as a young man
    • On the House by John Boehner — Republicans in Trump’s shadow
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

National Health Service

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 12 April, 2021
    Covid-19 vaccines
    NHS England starts offering Moderna jabs

    Johnson hails milestone in vaccinating most vulnerable groups as health service prepares to move on to under-50s

  • Sunday, 11 April, 2021
    FT CollectionsGreensill Capital
    Cameron lobbied Hancock on Greensill’s NHS pay scheme

    Former prime minister spoke to health secretary about finance company’s wage provider proposal

  • Sunday, 4 April, 2021
    UK politics & policy
    Rapid Covid tests to be offered to all in England

    Mass checks set out as Johnson prepares to detail next phases of lockdown easing

  • Tuesday, 30 March, 2021
    Coronavirus pandemic
    Return to school playing key role in slowing fall in UK Covid cases

    Debate under way on whether to let virus ‘run hot’ as pressure on hospitals eases

  • Monday, 29 March, 2021
    News in-depthCovid-19 vaccines
    London lags behind as the UK’s vaccine rollout gathers pace

    Hesitancy among ethnic minorities, deprivation and health inequalities may explain lower uptake of jab

  • Saturday, 27 March, 2021
    Murray Ellender
    Unchecked data harvesting undermines trust in the NHS

    Pandemic deals with digital health service providers were often made too hastily

  • Friday, 26 March, 2021
    Martin Weale
    How much are the Covid-19 jabs actually worth to us all?

    The success of the UK’s vaccine programme is reflected in our wellbeing but not in our national accounts

  • Thursday, 25 March, 2021
    Boris Johnson hints at bigger pay rise for England’s nurses

    Prime minister under pressure to put better deal on the table after Scottish government offers NHS staff a 4% increase

  • Wednesday, 24 March, 2021
    InterviewUK politics & policy
    Hancock says he can ‘see an end’ to coronavirus crisis

    Health secretary cites research suggesting vaccines are saving lives in the UK

  • Promoted Content
  • Friday, 19 March, 2021
    Covid-19 vaccines
    N Ireland waives sanctions on Republic residents seeking Covid jabs

    Irish people with NHS cards able to get vaccinated in North with doctors pushing for ‘all-island’ approach

  • Friday, 19 March, 2021
    Simon Wessely
    When lockdown ends, euphoria for some, fear for others

    Such emotions are natural, even healthy, and it is unhelpful to laden them with new medical diagnoses

  • Thursday, 18 March, 2021
    Covid-19 vaccines
    EU countries to restart use of AstraZeneca vaccine

    Germany, France, Spain and Italy reverse course after drugs regulator finds jab ‘safe and effective’

  • Thursday, 18 March, 2021
    Charles Calkin
    The lottery of later-life care

    Brexit derailed the debate on care — but politicians need to tackle the issue

  • Wednesday, 17 March, 2021
    Covid-19 vaccines
    NHS warns of ‘significant reduction’ in vaccine supplies

    Delays to jabs for under-50s but Hancock insists programme on course to reach all UK adults by end of July

  • Wednesday, 10 March, 2021
    UK politics & policy
    England’s £23bn test and trace programme condemned by MPs

    ‘Unimaginable’ level of spending made no ‘measurable difference’ to spread of virus, report finds

  • Tuesday, 9 March, 2021
    Coronavirus pandemic
    Fresh wave of Covid infections will hit UK this year, experts say

    UK government’s top scientific and medical advisers warn MPs against easing lockdown too quickly

  • Saturday, 6 March, 2021
    Mental health
    Horatio Clare: ‘There is no cure for being you or me’

    After suffering a breakdown, the acclaimed writer has found hope in new therapies

  • Saturday, 6 March, 2021
    Boris Johnson faces backlash over ‘pitiful’ NHS pay offer

    UK nurses’ leaders prepare for strike action as government insists 1 per cent rise is all it can afford

  • Friday, 5 March, 2021
    Coronavirus pandemic
    Mystery person with P.1 coronavirus variant in UK found

    Health secretary Matt Hancock praises NHS test and trace for ‘dogged determination’ in tracking individual down

  • Wednesday, 3 March, 2021
    Campaigners claim Budget fails to address stretched healthcare

    NHS funding set to fall as emergency Covid-19 support is scaled back

  • Monday, 1 March, 2021
    Coronavirus pandemic
    NHS doctors criticised over ‘do not resuscitate’ orders during pandemic

    Human rights group says denying treatment to some disabled and elderly patients is clear breach of the law

  • Friday, 26 February, 2021
    Coronavirus pandemic
    Rise in Covid infections reported in 1 in 5 English local authorities

    Public urged to stick to lockdown rules as regional disparities remain despite falls in UK-wide impact

  • Friday, 26 February, 2021
    UK business & economy
    Cancer drug is first to begin fast-track UK approval process

    Approach seeks to cut years off traditional licensing process for treatments

  • Thursday, 25 February, 2021
    UK lowers Covid alert level as hospital admissions fall

    Move means the NHS is no longer at risk of being overwhelmed, says government

  • Wednesday, 24 February, 2021
    Covid-19 vaccines
    People with learning disabilities prioritised in UK vaccine rollout

    Decision reflects concern that group has been hit much harder by Covid-19

Previous You are on page 1 Next

Topics related to Health & pharmaceuticals

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2021. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Graphics
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In